--- title: "The Winners, the Zombies, and the Desperate in Today's Market" type: "News" locale: "en" url: "https://longbridge.com/en/news/294796370.md" description: "The market is brutally bifurcated. While some infrastructure players are tripling profits off the AI boom, former cybersecurity titans are stalling, and a whole cohort of zombie stocks remains dead silent. Time to clean house." datetime: "2026-08-04T09:17:43.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294796370.md) - [en](https://longbridge.com/en/news/294796370.md) - [zh-HK](https://longbridge.com/zh-HK/news/294796370.md) generator: "portal-rs" --- # The Winners, the Zombies, and the Desperate in Today's Market I have said it a million times: ignore the PR spin and look at what these companies are actually doing. This random assortment of 10 US equities perfectly encapsulates the absolute bizarre bifurcation in the public markets right now. Some are printing money, some are staging desperate survival plays, and an alarming number are just playing dead. This is absurd, and here is why. Let's start with the absolute zeroes: INNEOVA HOLDINGS LIMITED (INEO.US), Primech Holdings Ltd (PMEC.US), QXO INC (QXO.US), and HANG FENG TECHNOLOGY INNOVATION CO LTD (FOFO.US). It is 2026. If you are a public company and you are utterly devoid of any recent market narrative or product updates, why are you even here? Go private and stop wasting everyone’s time. To these zombie stocks, I say: good luck with that. Then you have the players who actually get the joke. Look at SOLARIS ENERGY INFRASTRUCTURE INC (SEI.US). Pivoting from oilfield infrastructure to data center power solutions is hands down one of the smartest corporate maneuvers of the decade. They delivered USD 196.2M in revenue and over 300% net income growth in Q1 2026, locking down massive hyperscaler contracts. While everyone else is babbling about AI, they are literally keeping the lights on. It is no wonder Wall Street analysts recently upgraded them. But then you look at old-school tech and just sigh. CHECK POINT SOFTWARE TECHNOLOGIES (CHKP.US) managed a pathetic 1% total revenue growth in Q2 2026. In the middle of a global cybersecurity boom? You have got to be kidding me. Throwing USD 2B at stock buybacks does not cover up the fact that they are losing the innovation war to nimbler rivals. Their recent stock slide on weak Q3 guidance is exactly what happens when you fall asleep at the wheel. Over in crypto land, COINCHECK GROUP NV (CNCK.US) is doing something genuinely wild. A Dutch-held Japanese exchange managing Bitcoin reserves for a mindfulness city in Bhutan. It sounds like a bad sci-fi novel, but with KDDI's recent strategic backing, they might actually have the muscle to pull it off. I am watching this one closely. In biotech, it is the usual brutal waiting game. OUTLOOK THERAPEUTICS INC (OTLK.US) finally got its long-awaited FDA nod for wet AMD in July. Congratulations on passing the starting line; now let's see if you can actually sell it. Meanwhile, CO DIAGNOSTICS INC (CODX.US) is pivoting its PCR tech toward mosquito vector control and TB testing. It is a noble pivot, but they are stuck in FDA purgatory. Move faster, or get left behind. Finally, the desperation plays. THE GROWHUB LIMITED (TGHL.US) tried to sell the market on blockchain traceability, and the market responded by nearly delisting them. Now they are scrambling to merge with EnChem America just to keep their Nasdaq ticker. Sure, the stock surged over 40% recently on the news, but let's be honest: this is a life raft, not a rocket ship. My view is simple: reward the builders powering the infrastructure, and ruthlessly cut the dead weight. The market is getting smarter. Are you? *This article does not constitute investment advice.* ### Related Stocks - [INEO.US](https://longbridge.com/en/quote/INEO.US.md) - [CODX.US](https://longbridge.com/en/quote/CODX.US.md) - [PMEC.US](https://longbridge.com/en/quote/PMEC.US.md) - [CNCK.US](https://longbridge.com/en/quote/CNCK.US.md) - [SEI.US](https://longbridge.com/en/quote/SEI.US.md) - [QXO.US](https://longbridge.com/en/quote/QXO.US.md) - [OTLK.US](https://longbridge.com/en/quote/OTLK.US.md) - [FOFO.US](https://longbridge.com/en/quote/FOFO.US.md) - [CHKP.US](https://longbridge.com/en/quote/CHKP.US.md) - [TGHL.US](https://longbridge.com/en/quote/TGHL.US.md) ## Related News & Research - [Outlook Therapeutics, Inc. 2026: Revenue $8.7K, EPS ($0.15) — 10-Q Summary](https://longbridge.com/en/news/296273184.md) - [Co-Diagnostics submits FDA 510(k) for Co-Dx PCR Flu A/B & RSV point-of-care test](https://longbridge.com/en/news/296236160.md) - [Oncobiologics (NASDAQ:OTLK) Releases Earnings Results](https://longbridge.com/en/news/295985021.md) - [Coincheck Group publishes FY2026 annual report](https://longbridge.com/en/news/296566280.md) - [Outlook Therapeutics CFO Lawrence Kenyon acquires 101,010 common shares valued at $99,999.9](https://longbridge.com/en/news/295983837.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**